 |
Related Articles |
Resolution of methylphenidate osmotic release oral system-induced hair loss in two siblings after dose escalation.
Pediatr Int. 2017 Nov;59(11):1217-1218
Authors: Ardic UA, Ercan ES
Abstract
This report describes the cases of two siblings who experienced hair loss after treatment with methylphenidate (MPH) osmotic release oral system (OROS). Hair loss was resolved after discontinuation of the drug, but the children re-initiated treatment, after which hair loss again occurred, but they continued the treatment. After dose escalation, the hair loss resolved. This is the first report to describe resolution of OROS-MPH-induced hair loss after dose escalation.
PMID: 29359460 [PubMed – in process]
via https://www.ncbi.nlm.nih.gov/pubmed/29359460?dopt=Abstract